Universal Health International Group Holding Limited (HKG:2211)

HKG:2211 Income Statement

Financials in millions CNY. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	711.51	1,089	1,297	1,274	1,185
Revenue Growth (YoY)	-34.67%	-16.04%	1.84%	7.46%	-21.52%
Cost of Revenue	598.12	909.15	1,083	1,069	1,028
Gross Profit	113.39	179.89	213.85	204.16	156.9
Selling, General & Admin	136.32	205.6	303.12	380.35	600.36
Other Operating Expenses	-0.36	-1.81	-2.88	-6.46	-0
Operating Expenses	135.96	203.79	300.24	373.89	600.36
Operating Income	-22.57	-23.9	-86.39	-169.73	-443.45
Interest Expense	-0.95	-1.36	-1.27	-1.17	-1.07
Interest & Investment Income	0.58	0.6	0.93	2.87	1.25
Earnings From Equity Investments	0.66	1.73	-20.96	-1.63	3.22
Currency Exchange Gain (Loss)	2.49	-3.63	7.86	1.58	-10.68
Other Non Operating Income (Expenses)	-0.18	-0.21	-0.24	-0.15	-0.12
EBT Excluding Unusual Items	-19.97	-26.78	-100.07	-168.22	-450.85
Gain (Loss) on Sale of Investments	1.99	-	-10.43	-21.99	-210.76
Gain (Loss) on Sale of Assets	1.95	28.14	-1.93	1.79	-1.11
Asset Writedown	-6.9	-4.16	0.34	0.41	-8.09
Pretax Income	-22.94	-2.79	-112.11	-188.01	-670.8
Income Tax Expense	2.73	-3.37	-5.99	-	5.2
Earnings From Continuing Operations	-25.67	0.58	-106.12	-188.01	-676.01
Minority Interest in Earnings	-0.33	-0.17	0.72	0.37	0.61
Net Income	-26.01	0.41	-105.4	-187.65	-675.4
Net Income to Common	-26.01	0.41	-105.4	-187.65	-675.4
Shares Outstanding (Basic)	80	67	58	44	39
Shares Outstanding (Diluted)	80	67	58	44	39
Shares Change (YoY)	19.80%	14.67%	32.58%	13.85%	0.19%
EPS (Basic)	-0.32	0.01	-1.81	-4.27	-17.48
EPS (Diluted)	-0.32	0.01	-1.81	-4.27	-17.48
Free Cash Flow	-59.85	-101.75	-18.21	-42.52	-109.62
Free Cash Flow Per Share	-0.75	-1.52	-0.31	-0.97	-2.84
Gross Margin	15.94%	16.52%	16.49%	16.03%	13.24%
Operating Margin	-3.17%	-2.20%	-6.66%	-13.33%	-37.42%
Profit Margin	-3.65%	0.04%	-8.13%	-14.73%	-56.99%
Free Cash Flow Margin	-8.41%	-9.34%	-1.40%	-3.34%	-9.25%
EBITDA	-9	-10.21	-70.62	-151.19	-346.31
EBITDA Margin	-1.26%	-0.94%	-5.45%	-11.87%	-29.22%
D&A For EBITDA	13.58	13.69	15.77	18.54	97.14
EBIT	-22.57	-23.9	-86.39	-169.73	-443.45
EBIT Margin	-3.17%	-2.20%	-6.66%	-13.33%	-37.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.